NEW YORK (GenomeWeb News) – Gen-Probe and Affymetrix presented updates on their businesses for investors at the Thomas Weisel Healthcare Conference being held this week in Boston.

Gen-Probe officials said that the firm is on track with clinical trials for its Aptima HPV assay and expects to file for US Food and Drug Administration clearance of the test by the end of 2010. They also said that Panther, Gen-Probe's fully automated molecular instrument, is on schedule for a late 2010 launch in Europe, followed by a US launch in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.